Search

Stephen Johnson

Examiner (ID: 7683, Phone: (571)272-6877 , Office: P/3641 )

Most Active Art Unit
3641
Art Unit(s)
2201, 3641
Total Applications
3122
Issued Applications
2552
Pending Applications
138
Abandoned Applications
437

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4570901 [patent_doc_number] => 07824697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'High concentration baclofen preparations' [patent_app_type] => utility [patent_app_number] => 11/156370 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7062 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/824/07824697.pdf [firstpage_image] =>[orig_patent_app_number] => 11156370 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/156370
High concentration baclofen preparations Jun 16, 2005 Issued
Array ( [id] => 5277898 [patent_doc_number] => 20090130030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Plural Activating Optical Change Toothpastes, Stimuli and Elements' [patent_app_type] => utility [patent_app_number] => 11/629113 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7837 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130030.pdf [firstpage_image] =>[orig_patent_app_number] => 11629113 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/629113
Plural Activating Optical Change Toothpastes, Stimuli and Elements Jun 9, 2005 Abandoned
Array ( [id] => 5064086 [patent_doc_number] => 20070225727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Transparent Tissue-Visualizng Preparation' [patent_app_type] => utility [patent_app_number] => 11/597976 [patent_app_country] => US [patent_app_date] => 2005-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9821 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225727.pdf [firstpage_image] =>[orig_patent_app_number] => 11597976 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/597976
Transparent Tissue-Visualizng Preparation May 29, 2005 Abandoned
Array ( [id] => 5182618 [patent_doc_number] => 20070053964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist' [patent_app_type] => utility [patent_app_number] => 10/569772 [patent_app_country] => US [patent_app_date] => 2005-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8455 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20070053964.pdf [firstpage_image] =>[orig_patent_app_number] => 10569772 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/569772
Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist May 19, 2005 Abandoned
Array ( [id] => 5590503 [patent_doc_number] => 20060039954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Ocular formulations with neuroprotectants to reduce Alzheimer and neurotoxic risks created by large zinc dosages' [patent_app_type] => utility [patent_app_number] => 11/133125 [patent_app_country] => US [patent_app_date] => 2005-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 37426 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20060039954.pdf [firstpage_image] =>[orig_patent_app_number] => 11133125 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/133125
Ocular formulations with neuroprotectants to reduce Alzheimer and neurotoxic risks created by large zinc dosages May 17, 2005 Abandoned
Array ( [id] => 7046161 [patent_doc_number] => 20050250756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration' [patent_app_type] => utility [patent_app_number] => 11/125932 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5604 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250756.pdf [firstpage_image] =>[orig_patent_app_number] => 11125932 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/125932
Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration May 9, 2005 Abandoned
Array ( [id] => 7045226 [patent_doc_number] => 20050249821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Nutritional supplement for treatment of ocular diseases' [patent_app_type] => utility [patent_app_number] => 11/122481 [patent_app_country] => US [patent_app_date] => 2005-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5031 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20050249821.pdf [firstpage_image] =>[orig_patent_app_number] => 11122481 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/122481
Nutritional supplement for treatment of ocular diseases May 4, 2005 Issued
Array ( [id] => 5835489 [patent_doc_number] => 20060247321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Abnormal Cannabidiols as agents useful in combination therapy for lowering intraocular pressure' [patent_app_type] => utility [patent_app_number] => 11/121528 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2237 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247321.pdf [firstpage_image] =>[orig_patent_app_number] => 11121528 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/121528
Abnormal Cannabidiols as agents useful in combination therapy for lowering intraocular pressure May 1, 2005 Abandoned
Array ( [id] => 7069093 [patent_doc_number] => 20050244476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Intraocular implants and methods for improving vision' [patent_app_type] => utility [patent_app_number] => 11/119021 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17809 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244476.pdf [firstpage_image] =>[orig_patent_app_number] => 11119021 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/119021
Intraocular implants and methods for improving vision Apr 28, 2005 Issued
Array ( [id] => 7244106 [patent_doc_number] => 20050271705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Retinoid-containing sustained release intraocular drug delivery system and related methods' [patent_app_type] => utility [patent_app_number] => 11/119024 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 27534 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271705.pdf [firstpage_image] =>[orig_patent_app_number] => 11119024 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/119024
Retinoid-containing sustained release intraocular drug delivery system and related methods Apr 28, 2005 Abandoned
Array ( [id] => 5835434 [patent_doc_number] => 20060247265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Therapies for treating disorders of the eye' [patent_app_type] => utility [patent_app_number] => 11/116942 [patent_app_country] => US [patent_app_date] => 2005-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3550 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247265.pdf [firstpage_image] =>[orig_patent_app_number] => 11116942 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/116942
Therapies for treating disorders of the eye Apr 27, 2005 Abandoned
Array ( [id] => 5771636 [patent_doc_number] => 20050267087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Inflammatory eye disease' [patent_app_type] => utility [patent_app_number] => 11/115687 [patent_app_country] => US [patent_app_date] => 2005-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7380 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267087.pdf [firstpage_image] =>[orig_patent_app_number] => 11115687 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/115687
Inflammatory eye disease Apr 26, 2005 Abandoned
Array ( [id] => 4977909 [patent_doc_number] => 20070219142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye' [patent_app_type] => utility [patent_app_number] => 11/568144 [patent_app_country] => US [patent_app_date] => 2005-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3584 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219142.pdf [firstpage_image] =>[orig_patent_app_number] => 11568144 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/568144
Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye Apr 24, 2005 Abandoned
Array ( [id] => 6926501 [patent_doc_number] => 20050239757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Hormone treatment of macular degeneration' [patent_app_type] => utility [patent_app_number] => 11/110199 [patent_app_country] => US [patent_app_date] => 2005-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4848 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239757.pdf [firstpage_image] =>[orig_patent_app_number] => 11110199 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/110199
Hormone treatment of macular degeneration Apr 19, 2005 Abandoned
Array ( [id] => 5754601 [patent_doc_number] => 20060223750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Agents and methods for enhancing photodynamic therapy' [patent_app_type] => utility [patent_app_number] => 11/096886 [patent_app_country] => US [patent_app_date] => 2005-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4165 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223750.pdf [firstpage_image] =>[orig_patent_app_number] => 11096886 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/096886
Agents and methods for enhancing photodynamic therapy Mar 31, 2005 Abandoned
Array ( [id] => 5101956 [patent_doc_number] => 20070185218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Controlled release formulation for oral administration of metformin' [patent_app_type] => utility [patent_app_number] => 10/599500 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2725 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185218.pdf [firstpage_image] =>[orig_patent_app_number] => 10599500 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/599500
Controlled release formulation for oral administration of metformin Mar 30, 2005 Abandoned
Array ( [id] => 5159480 [patent_doc_number] => 20070172524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Process for preparing a solid pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 10/599154 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2310 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172524.pdf [firstpage_image] =>[orig_patent_app_number] => 10599154 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/599154
Process for preparing a solid pharmaceutical composition Mar 28, 2005 Abandoned
11/091328 Triple-action remedy for removing toxic oils from skin with simultaneous soothing and healing Mar 27, 2005 Abandoned
Array ( [id] => 5766616 [patent_doc_number] => 20060018847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations' [patent_app_type] => utility [patent_app_number] => 11/090693 [patent_app_country] => US [patent_app_date] => 2005-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6760 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018847.pdf [firstpage_image] =>[orig_patent_app_number] => 11090693 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/090693
Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations Mar 24, 2005 Abandoned
Array ( [id] => 5705847 [patent_doc_number] => 20060194895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Dental compositions having dual dental diagnostic capabilities and methods of use' [patent_app_type] => utility [patent_app_number] => 11/065747 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7886 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194895.pdf [firstpage_image] =>[orig_patent_app_number] => 11065747 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/065747
Dental compositions having dual dental diagnostic capabilities and methods of use Feb 24, 2005 Abandoned
Menu